25.46
0.04%
+0.005
Deciphera Pharmaceuticals Inc (DCPH) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
11.50%
48.29
|
43.31 | 38.30 | 33.45 | 36.34 |
Cost Of Revenue |
38.80%
1.785
|
1.286 | 0.173 | 0.488 | 3.245 |
Gross Profit |
10.66%
46.51
|
42.03 | 38.13 | 32.96 | 33.10 |
Operating Expenses
|
2.12%
97.75
|
95.72 | 90.91 | 86.21 | 80.26 |
Benefits Costs and Expenses |
14.35%
83.08
|
97.00 | 91.08 | 86.70 | 78.99 |
Costs And Expenses |
2.61%
99.53
|
97.00 | 91.08 | 86.70 | 83.51 |
Operating Income/Loss |
4.56%
-51.24
|
-53.69 | -52.77 | -53.26 | -47.16 |
Nonoperating Income/Loss |
9.06%
4.479
|
4.107 | 4.213 | 3.648 | 1.948 |
Income/Loss From Continuing Operations Before Tax |
35.20%
-34.79
|
-53.69 | -52.77 | -178.90 | -42.65 |
Income/Loss From Continuing Operations After Tax |
4.82%
-47.19
|
-49.58 | -48.56 | -178.90 | -45.94 |
Net Income/Loss
|
4.82%
-47.19
|
-49.58 | -48.56 | -178.90 | -45.94 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.35%
0.5534
|
85.79 | 85.02 | 82.68 | 2.3703 |
Diluted Average Shares |
99.35%
0.5534
|
85.79 | 85.02 | 82.68 | 2.3703 |
Basic Earnings Per Share |
6.90%
-0.54
|
-0.58 | -0.57 | -0.60 | -0.55 |
Diluted Earnings Per Share |
6.90%
-0.54
|
-0.58 | -0.57 | -0.60 | -0.55 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):